Lv4
428 积分 2021-07-06 加入
Beyond PI3Ks: targeting phosphoinositide kinases in disease
15天前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
1个月前
已完结
Recent discovery and development of AXL inhibitors as antitumor agents
1个月前
已完结
230 (PB218): Combining OP-3136, a KAT6 inhibitor, with endocrine therapy and CDK4/6 inhibitor enhances anti-tumor activity in ER+/HER2- breast cancer models
2个月前
已关闭
Potential new therapeutic target for HFpEF
2个月前
已完结
Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy
2个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
2个月前
已完结
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies
2个月前
已完结
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
2个月前
已完结
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
2个月前
已完结
皖公网安备34019202002308
